Online inquiry

IVTScrip™ mRNA-Anti-LYPD3, BAY 1112623(Cap 0, 2-Thio-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ3575MR)

This product GTTS-WQ3575MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the monoclonal antibody that targets LYPD3 gene. The antibody can be applied in Cancers research.

Specifications
Product type	mRNA
Modified bases	2-Thio-UTP
5' Cap	Cap 0
Species	Homo sapiens
RefSeq	NM_014400.3
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	27076
UniProt ID	O95274

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-LYPD3, BAY 1112623(Cap 0, 2-Thio-UTP, 120 nt-poly(A)) (GTTS-WQ3575MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ3388MR	IVTScrip™ mRNA-Anti-Canlupfam CD52, AT-005(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	AT-005
GTTS-WQ2163MR	IVTScrip™ mRNA-Anti-IL6, ALD-518(Cap 0, 2-Thio-UTP, 120 nt-poly(A))	mRNA	ALD-518
GTTS-WQ10006MR	IVTScrip™ mRNA-Anti-FGF23, KRN-23(Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	KRN-23
GTTS-WQ8477MR	IVTScrip™ mRNA-Anti-CD274, HTI-1088(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	HTI-1088
GTTS-WQ6577MR	IVTScrip™ mRNA-Anti-EGFR, DC-1630423(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	DC-1630423
GTTS-WQ15296MR	IVTScrip™ mRNA-Anti-EGFR, Theraloc(Cap 1, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	Theraloc
GTTS-WQ11833MR	IVTScrip™ mRNA-Anti-LAG3, MK-4280(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	MK-4280
GTTS-WQ10565MR	IVTScrip™ mRNA-Anti-IL23A, LY3074828(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	LY3074828

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST